
Trastuzumab Biosimilar Adoption Increased in Japan Due to Reimbursement
Reimbursement incentives significantly increased the market uptake of trastuzumab biosimilars for cancer treatment but failed to produce a similar effect for bevacizumab biosimilars, suggesting policy makers design reimbursement strategies tailored to each …